{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:14:33Z","timestamp":1787681673191,"version":"build-2784847793"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NTNU Norwegian University of Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Persistent symptoms attributed to tick bites or tick-borne diseases are poorly understood. We estimate regionally adjusted prevalence of persistent symptoms, investigate seroprevalence (IgG) and ongoing infections, and examine associated demographic and clinical factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Persons aged 18 years or older with persistent symptoms lasting six months or more attributed to tick bites or tick-borne diseases, were recruited into a nationwide cross-sectional study. Demographic data were recorded. Medical records were collected (February 2020 - April 2022) and reviewed for tick bites, tick-borne infections, antibiotic treatment, and clinical findings. Outcome measures included somatic symptoms (PHQ-15), fatigue (Fatigue Severity Scale), physical health (RAND-36), and affective symptoms (HAD Scale). Laboratory assessments included polymerase chain reaction (PCR) analysis of blood samples for\n                      <jats:italic>Borrelia burgdorferi<\/jats:italic>\n                      (Bb) and other known tick-borne pathogens, along with IgG antibody detection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The highest prevalence of persistent symptoms attributed to tick bites or tick-borne diseases was found in southwestern Norway (0.152\u20130.155%); the lowest was in the north (0.033%), which also had significantly lower\n                      <jats:italic>Bb<\/jats:italic>\n                      -IgG seroprevalence (15.4% compared to the national average 37.5%). Symptom persistence was not associated with confirmed tick exposure or tick-borne infection. Somatic symptoms were associated with low physical activity and comorbidity. Fatigue and poor physical health were strongly associated with underemployment. Fatigue was also associated with depressive symptoms, low activity, sick leave, and comorbidities.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Persistent symptoms were most prevalent in tick-endemic regions but were not associated with prior tick exposure or tick-borne infections. Symptom burden was primarily associated with comorbidities, especially physical inactivity and underemployment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12182-w","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T09:13:36Z","timestamp":1764234816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and clinical characteristics of Norwegians who report persistent health complaints attributed to tick bites or tick-borne diseases"],"prefix":"10.1186","volume":"25","author":[{"given":"Audun Olav","family":"Dahlberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audun","family":"Aase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Reiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Quarsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ivind","family":"\u00d8ines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune","family":"Midgard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"12182_CR1","doi-asserted-by":"publisher","first-page":"m1041","DOI":"10.1136\/bmj.m1041","volume":"369","author":"BJ Kullberg","year":"2020","unstructured":"Kullberg BJ, Vrijmoeth HD, van de Schoor F, Hovius JW. Lyme borreliosis: diagnosis and management. BMJ. 2020;369:m1041. https:\/\/doi.org\/10.1136\/bmj.m1041.","journal-title":"BMJ"},{"issue":"1","key":"12182_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1186\/s12879-025-11104-0","volume":"25","author":"AO Dahlberg","year":"2025","unstructured":"Dahlberg AO, Aase A, Reiso H, Thortveit E, Eikeland R, Engstr\u00f8m M, Midgard R. Persistent self-reported health complaints in Norwegians who attribute their symptoms to tick bites or tick-borne disease- a cross-sectional controlled study. BMC Infect Dis. 2025;25(1):711. https:\/\/doi.org\/10.1186\/s12879-025-11104-0.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"12182_CR3","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/eurpub\/ckv091","volume":"25","author":"CC van den Wijngaard","year":"2015","unstructured":"van den Wijngaard CC, Hofhuis A, Harms MG, Haagsma JA, Wong A, de Wit GA, Havelaar AH, Lugner AK, Suijkerbuijk AW, van Pelt W. The burden of Lyme borreliosis expressed in disability-adjusted life years. Eur J Public Health. 2015;25(6):1071\u20138. https:\/\/doi.org\/10.1093\/eurpub\/ckv091.","journal-title":"Eur J Public Health"},{"issue":"4","key":"12182_CR4","doi-asserted-by":"publisher","first-page":"e0123274","DOI":"10.1371\/journal.pone.0123274","volume":"10","author":"J van Eck","year":"2015","unstructured":"van Eck J, Ten Have M, Rijnders C, van Marwijk H, de Graaf R, van der Feltz-Cornelis C. Medically unexplained and explained physical symptoms in the general population: association with prevalent and incident mental disorders. PLoS ONE. 2015;10(4):e0123274. https:\/\/doi.org\/10.1371\/journal.pone.0123274.","journal-title":"PLoS ONE"},{"issue":"2","key":"12182_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.idc.2015.02.006","volume":"29","author":"PM Lantos","year":"2015","unstructured":"Lantos PM. Chronic Lyme disease. Infect Dis Clin North Am. 2015;29(2):325\u201340. https:\/\/doi.org\/10.1016\/j.idc.2015.02.006.","journal-title":"Infect Dis Clin North Am"},{"issue":"9","key":"12182_CR6","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1586\/14787210.2014.940900","volume":"12","author":"DJ Cameron","year":"2014","unstructured":"Cameron DJ, Johnson LB, Maloney EL. Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema Migrans rashes and persistent disease. Expert Rev Anti Infect Ther. 2014;12(9):1103\u201335. https:\/\/doi.org\/10.1586\/14787210.2014.940900.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"12182_CR7","doi-asserted-by":"publisher","unstructured":"Lantos PM, Rumbaugh J, Bockenstedt LK, Falck-Ytter YT, Aguero-Rosenfeld ME, Auwaerter PG, Baldwin K, Bannuru RR, Belani KK, Bowie WR, American College of Rheumatology (ACR). Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and : 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2021;72(1):e1-e48. https:\/\/doi.org\/10.1093\/cid\/ciaa1215","DOI":"10.1093\/cid\/ciaa1215"},{"issue":"8","key":"12182_CR8","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/j.1468-1331.2012.03691.x","volume":"19","author":"U Ljostad","year":"2012","unstructured":"Ljostad U, Mygland A. The phenomenon of \u2018chronic Lyme\u2019; an observational study. Eur J Neurol. 2012;19(8):1128\u201335. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03691.x.","journal-title":"Eur J Neurol"},{"issue":"4","key":"12182_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1468-1331.2010.03229.x","volume":"18","author":"M Djukic","year":"2011","unstructured":"Djukic M, Schmidt-Samoa C, Nau R, von Steinbuchel N, Eiffert H, Schmidt H. The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis\u2013the experience from one year of a university hospital\u2019s Lyme neuroborreliosis outpatients clinic. Eur J Neurol. 2011;18(4):547\u201355. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03229.x.","journal-title":"Eur J Neurol"},{"issue":"14","key":"12182_CR10","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1056\/NEJMra072023","volume":"357","author":"HM Feder Jr","year":"2007","unstructured":"Feder HM Jr., Johnson BJ, O\u2019Connell S, Shapiro ED, Steere AC, Wormser GP, Agger WA, Artsob H, Auwaerter P, Dumler JS, et al. A critical appraisal of chronic Lyme disease. N Engl J Med. 2007;357(14):1422\u201330. https:\/\/doi.org\/10.1056\/NEJMra072023.","journal-title":"N Engl J Med"},{"key":"12182_CR11","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2147\/ijgm.S23829","volume":"4","author":"RB Stricker","year":"2011","unstructured":"Stricker RB, Delong AK, Green CL, Savely VR, Chamallas SN, Johnson L. Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease. Int J Gen Med. 2011;4:639\u201346. https:\/\/doi.org\/10.2147\/ijgm.S23829.","journal-title":"Int J Gen Med"},{"issue":"13","key":"12182_CR12","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa1505425","volume":"374","author":"A Berende","year":"2016","unstructured":"Berende A, ter Hofstede HJ, Vos FJ, van Middendorp H, Vogelaar ML, Tromp M, van den Hoogen FH, Donders AR, Evers AW, Kullberg BJ. Randomized trial of Longer-Term therapy for symptoms attributed to Lyme disease. N Engl J Med. 2016;374(13):1209\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1505425.","journal-title":"N Engl J Med"},{"key":"12182_CR13","doi-asserted-by":"publisher","first-page":"104825","DOI":"10.1016\/j.ebiom.2023.104825","volume":"98","author":"HD Vrijmoeth","year":"2023","unstructured":"Vrijmoeth HD, Ursinus J, Harms MG, Tulen AD, Baarsma ME, van de Schoor FR, Gauw SA, Zomer TP, Vermeeren YM, Ferreira JA, et al. Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study. EBioMedicine. 2023;98:104825. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104825.","journal-title":"EBioMedicine"},{"issue":"Supplement1","key":"12182_CR14","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1093\/infdis\/jiae203","volume":"230","author":"ME Baarsma","year":"2024","unstructured":"Baarsma ME, Hovius JW. Persistent symptoms after Lyme disease: clinical Characteristics, Predictors, and classification. J Infect Dis. 2024;230(Supplement1):S62\u20139. https:\/\/doi.org\/10.1093\/infdis\/jiae203.","journal-title":"J Infect Dis"},{"key":"12182_CR15","doi-asserted-by":"publisher","first-page":"100142","DOI":"10.1016\/j.lanepe.2021.100142","volume":"6","author":"J Ursinus","year":"2021","unstructured":"Ursinus J, Vrijmoeth HD, Harms MG, Tulen AD, Knoop H, Gauw SA, Zomer TP, Wong A, Friesema IHM, Vermeeren YM, et al. Prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study. Lancet Reg Health Eur. 2021;6:100142. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100142.","journal-title":"Lancet Reg Health Eur"},{"issue":"2","key":"12182_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/00006842-200203000-00008","volume":"64","author":"K Kroenke","year":"2002","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64(2):258\u201366. https:\/\/doi.org\/10.1097\/00006842-200203000-00008.","journal-title":"Psychosom Med"},{"issue":"10","key":"12182_CR17","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121\u20133. https:\/\/doi.org\/10.1001\/archneur.1989.00520460115022.","journal-title":"Arch Neurol"},{"issue":"2","key":"12182_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s0022-3999(01)00296-3","volume":"52","author":"I Bjelland","year":"2002","unstructured":"Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69\u201377. https:\/\/doi.org\/10.1016\/s0022-3999(01)00296-3.","journal-title":"J Psychosom Res"},{"issue":"2","key":"12182_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/sjop.12029","volume":"54","author":"S Nordin","year":"2013","unstructured":"Nordin S, Palmquist E, Nordin M. Psychometric evaluation and normative data for a Swedish version of the patient health questionnaire 15-Item somatic symptom severity scale. Scand J Psychol. 2013;54(2):112\u20137. https:\/\/doi.org\/10.1111\/sjop.12029.","journal-title":"Scand J Psychol"},{"issue":"1","key":"12182_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12955-017-0625-9","volume":"15","author":"AM Garratt","year":"2017","unstructured":"Garratt AM, Stavem K. Measurement properties and normative data for the Norwegian SF-36: results from a general population survey. Health Qual Life Outcomes. 2017;15(1):51. https:\/\/doi.org\/10.1186\/s12955-017-0625-9.","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"12182_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/14034940410028406","volume":"33","author":"A Lerdal","year":"2005","unstructured":"Lerdal A, Wahl A, Rust\u00f8en T, Hanestad BR, Moum T. Fatigue in the general population: a translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scand J Public Health. 2005;33(2):123\u201330. https:\/\/doi.org\/10.1080\/14034940410028406.","journal-title":"Scand J Public Health"},{"key":"12182_CR22","unstructured":"Leiknes KA, Dalsb\u00f8 TK, Siqveland J. M\u00e5leegenskaper Ved Den Norske versjonen av hospital anxiety and depression scale (HADS).[Psychometric assessment of the Norwegian version of the hospital anxiety and depression scale (HADS)]. Rapport Fra Kunnskapssenteret 2016."},{"key":"12182_CR23","unstructured":"https:\/\/www.medcalc.org\/"},{"issue":"1","key":"12182_CR24","doi-asserted-by":"publisher","first-page":"102391","DOI":"10.1016\/j.ttbdis.2024.102391","volume":"16","author":"AO Dahlberg","year":"2024","unstructured":"Dahlberg AO, Aase A, Reiso H, Midgard R, Quarsten H. Detection of Neoehrlichia mikurensis in 11 persons who attribute their persistent health complaints to a tick-borne disease. Ticks Tick Borne Dis. 2024;16(1):102391. https:\/\/doi.org\/10.1016\/j.ttbdis.2024.102391.","journal-title":"Ticks Tick Borne Dis"},{"issue":"1","key":"12182_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ttbdis.2016.06.006","volume":"8","author":"KE Eliassen","year":"2017","unstructured":"Eliassen KE, Berild D, Reiso H, Grude N, Christophersen KS, Finckenhagen C, Lindbaek M. Incidence and antibiotic treatment of erythema Migrans in Norway 2005\u20132009. Ticks Tick Borne Dis. 2017;8(1):1\u20138. https:\/\/doi.org\/10.1016\/j.ttbdis.2016.06.006.","journal-title":"Ticks Tick Borne Dis"},{"issue":"1","key":"12182_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12889-019-6681-9","volume":"19","author":"A DeLong","year":"2019","unstructured":"DeLong A, Hsu M, Kotsoris H. Estimation of cumulative number of post-treatment Lyme disease cases in the US, 2016 and 2020. BMC Public Health. 2019;19(1):352. https:\/\/doi.org\/10.1186\/s12889-019-6681-9.","journal-title":"BMC Public Health"},{"key":"12182_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1756-3305-4-84","volume":"4","author":"S Jore","year":"2011","unstructured":"Jore S, Viljugrein H, Hofshagen M, Brun-Hansen H, Kristoffersen AB, Nyg\u00e5rd K, Brun E, Ottesen P, S\u00e6vik BK, Ytrehus B. Multi-source analysis reveals latitudinal and altitudinal shifts in range of Ixodes ricinus at its Northern distribution limit. Parasit Vectors. 2011;4:84. https:\/\/doi.org\/10.1186\/1756-3305-4-84.","journal-title":"Parasit Vectors"},{"key":"12182_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12889-015-1539-2","volume":"15","author":"C Aenishaenslin","year":"2015","unstructured":"Aenishaenslin C, Michel P, Ravel A, Gern L, Milord F, Waaub JP, B\u00e9langer D. Factors associated with preventive behaviors regarding Lyme disease in Canada and switzerland: a comparative study. BMC Public Health. 2015;15:185. https:\/\/doi.org\/10.1186\/s12889-015-1539-2.","journal-title":"BMC Public Health"},{"issue":"3","key":"12182_CR29","doi-asserted-by":"publisher","first-page":"101925","DOI":"10.1016\/j.ttbdis.2022.101925","volume":"13","author":"A Beck","year":"2022","unstructured":"Beck A, Bjork J, Biggerstaff BJ, Eisen L, Eisen R, Foster E, Signs K, Tsao JI, Kough E, Peterson M, et al. Knowledge, attitudes, and behaviors regarding tick-borne disease prevention in Lyme disease-endemic areas of the upper Midwest, united States. Ticks Tick Borne Dis. 2022;13(3):101925. https:\/\/doi.org\/10.1016\/j.ttbdis.2022.101925.","journal-title":"Ticks Tick Borne Dis"},{"issue":"4","key":"12182_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.amjmed.2021.10.040","volume":"135","author":"T Kobayashi","year":"2022","unstructured":"Kobayashi T, Higgins Y, Melia MT, Auwaerter PG. Mistaken identity: many diagnoses are frequently misattributed to Lyme disease. Am J Med. 2022;135(4):503\u2013e511505. https:\/\/doi.org\/10.1016\/j.amjmed.2021.10.040.","journal-title":"Am J Med"},{"issue":"5","key":"12182_CR31","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ttbdis.2016.02.020","volume":"7","author":"DF Vestrheim","year":"2016","unstructured":"Vestrheim DF, White RA, Aaberge IS, Aase A. Geographical differences in Seroprevalence of borrelia burgdorferi antibodies in Norway, 2011\u20132013. Ticks Tick Borne Dis. 2016;7(5):698\u2013702. https:\/\/doi.org\/10.1016\/j.ttbdis.2016.02.020.","journal-title":"Ticks Tick Borne Dis"},{"issue":"4","key":"12182_CR32","doi-asserted-by":"publisher","first-page":"101410","DOI":"10.1016\/j.ttbdis.2020.101410","volume":"11","author":"ET Thortveit","year":"2020","unstructured":"Thortveit ET, Aase A, Petersen LB, Lorentzen \u00c5R, Mygland \u00c5, Lj\u00f8stad U. Human Seroprevalence of antibodies to tick-borne microbes in Southern Norway. Ticks Tick Borne Dis. 2020;11(4):101410. https:\/\/doi.org\/10.1016\/j.ttbdis.2020.101410.","journal-title":"Ticks Tick Borne Dis"},{"key":"12182_CR33","doi-asserted-by":"publisher","unstructured":"Branda JA, Steere AC. Laboratory diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2021;34(2). https:\/\/doi.org\/10.1128\/cmr.00018-19.","DOI":"10.1128\/cmr.00018-19"},{"issue":"6","key":"12182_CR34","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1128\/jcm.32.6.1519-1525.1994","volume":"32","author":"S Hammers-Berggren","year":"1994","unstructured":"Hammers-Berggren S, Lebech AM, Karlsson M, Svenungsson B, Hansen K, Stiernstedt G. Serological follow-up after treatment of patients with erythema Migrans and neuroborreliosis. J Clin Microbiol. 1994;32(6):1519\u201325. https:\/\/doi.org\/10.1128\/jcm.32.6.1519-1525.1994.","journal-title":"J Clin Microbiol"},{"key":"12182_CR35","doi-asserted-by":"publisher","first-page":"580102","DOI":"10.3389\/fpubh.2021.580102","volume":"9","author":"AJ Henningsson","year":"2021","unstructured":"Henningsson AJ, Aase A, Bavelaar H, Flottorp S, Forsberg P, Kirkehei I, L\u00f6vmar M, Nilsson K, Nyman D, Ornstein K, et al. Laboratory methods for detection of infectious agents and serological response in humans with Tick-Borne infections: A systematic review of evaluations based on clinical patient samples. Front Public Health. 2021;9:580102. https:\/\/doi.org\/10.3389\/fpubh.2021.580102.","journal-title":"Front Public Health"},{"issue":"1","key":"12182_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12866-019-1502-y","volume":"19","author":"A Jenkins","year":"2019","unstructured":"Jenkins A, Raasok C, Pedersen BN, Jensen K, Andreassen \u00c5, Soleng A, Edgar KS, Lindstedt HH, Kjelland V, Stuen S, et al. Detection of candidatus Neoehrlichia mikurensis in Norway up to the Northern limit of Ixodes ricinus distribution using a novel real time PCR test targeting the GroEL gene. BMC Microbiol. 2019;19(1):199. https:\/\/doi.org\/10.1186\/s12866-019-1502-y.","journal-title":"BMC Microbiol"},{"key":"12182_CR37","doi-asserted-by":"publisher","first-page":"105655","DOI":"10.1016\/j.meegid.2024.105655","volume":"123","author":"P Khademi","year":"2024","unstructured":"Khademi P, Tukmechi A, Sgroi G, Ownagh A, Enferadi A, Khalili M, Mardani K. Molecular and genotyping techniques in diagnosis of Coxiella burnetii: an overview. Infect Genet Evol. 2024;123:105655. https:\/\/doi.org\/10.1016\/j.meegid.2024.105655.","journal-title":"Infect Genet Evol"},{"issue":"10","key":"12182_CR38","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1002\/ejp.2307","volume":"28","author":"M Glette","year":"2024","unstructured":"Glette M, Stiles TC, Woodhouse A, Nilsen TIL, Landmark T. Chronic fatigue in the general population: Prevalence, natural course and associations with chronic pain (the HUNT pain study). Eur J Pain. 2024;28(10):1762\u201371. https:\/\/doi.org\/10.1002\/ejp.2307.","journal-title":"Eur J Pain"},{"key":"12182_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12916-014-0167-5","volume":"12","author":"IJ Bakken","year":"2014","unstructured":"Bakken IJ, Tveito K, Gunnes N, Ghaderi S, Stoltenberg C, Trogstad L, H\u00e5berg SE, Magnus P. Two age peaks in the incidence of chronic fatigue syndrome\/myalgic encephalomyelitis: a population-based registry study from Norway 2008\u20132012. BMC Med. 2014;12:167. https:\/\/doi.org\/10.1186\/s12916-014-0167-5.","journal-title":"BMC Med"},{"issue":"1","key":"12182_CR40","doi-asserted-by":"publisher","first-page":"7892","DOI":"10.1038\/s41467-023-43661-w","volume":"14","author":"CE Hastie","year":"2023","unstructured":"Hastie CE, Lowe DJ, McAuley A, Mills NL, Winter AJ, Black C, Scott JT, O\u2019Donnell CA, Blane DN, Browne S, et al. True prevalence of long-COVID in a nationwide, population cohort study. Nat Commun. 2023;14(1):7892. https:\/\/doi.org\/10.1038\/s41467-023-43661-w.","journal-title":"Nat Commun"},{"issue":"1","key":"12182_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1556\/1886.2015.00049","volume":"6","author":"E Sapi","year":"2016","unstructured":"Sapi E, Balasubramanian K, Poruri A, Maghsoudlou JS, Socarras KM, Timmaraju AV, Filush KR, Gupta K, Shaikh S, Theophilus PA, et al. Evidence of in vivo existence of borrelia biofilm in borrelial lymphocytomas. Eur J Microbiol Immunol (Bp). 2016;6(1):9\u201324. https:\/\/doi.org\/10.1556\/1886.2015.00049.","journal-title":"Eur J Microbiol Immunol (Bp)"},{"issue":"9","key":"12182_CR42","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"GP Wormser","year":"2006","unstructured":"Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the infectious diseases society of America. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2006;43(9):1089\u2013134. https:\/\/doi.org\/10.1086\/508667.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"795","key":"12182_CR43","doi-asserted-by":"publisher","first-page":"eadr2955","DOI":"10.1126\/scitranslmed.adr2955","volume":"17","author":"ME McClune","year":"2025","unstructured":"McClune ME, Ebohon O, Dressler JM, Davis MM, Tupik JD, Lochhead RB, Booth CJ, Steere AC, Jutras BL. The peptidoglycan of borrelia burgdorferi can persist in discrete tissues and cause systemic responses consistent with chronic illness. Sci Transl Med. 2025;17(795):eadr2955. https:\/\/doi.org\/10.1126\/scitranslmed.adr2955.","journal-title":"Sci Transl Med"},{"issue":"2","key":"12182_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/nejm200107123450202","volume":"345","author":"MS Klempner","year":"2001","unstructured":"Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP, Norton D, Levy L, Wall D, McCall J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001;345(2):85\u201392. https:\/\/doi.org\/10.1056\/nejm200107123450202.","journal-title":"N Engl J Med"},{"issue":"11","key":"12182_CR45","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1136\/jnnp-2022-329724","volume":"93","author":"AM Solheim","year":"2022","unstructured":"Solheim AM, Lorentzen \u00c5R, Dahlberg AO, Flemmen H, Brune S, Forselv KJN, Pripp AH, B\u00f8 MH, Eikeland R, Reiso H, et al. Six versus 2 weeks treatment with Doxycycline in European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blinded, randomised and placebo-controlled trial. J Neurol Neurosurg Psychiatry. 2022;93(11):1222\u20138. https:\/\/doi.org\/10.1136\/jnnp-2022-329724.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10474","key":"12182_CR46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/s0140-6736(25)00094-7","volume":"405","author":"L The","year":"2025","unstructured":"The L. Health in the age of disinformation. Lancet. 2025;405(10474):173. https:\/\/doi.org\/10.1016\/s0140-6736(25)00094-7.","journal-title":"Lancet"},{"issue":"1","key":"12182_CR47","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.medmal.2020.09.026","volume":"51","author":"X Gocko","year":"2021","unstructured":"Gocko X, Tattevin P, Lemogne C. Genesis and dissemination of a controversial disease: chronic Lyme. Infect Dis now. 2021;51(1):86\u20139. https:\/\/doi.org\/10.1016\/j.medmal.2020.09.026.","journal-title":"Infect Dis now"},{"issue":"10","key":"12182_CR48","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41582-022-00711-z","volume":"18","author":"M Fiorio","year":"2022","unstructured":"Fiorio M, Braga M, Marotta A, Villa-S\u00e1nchez B, Edwards MJ, Tinazzi M, Barbiani D. Functional neurological disorder and placebo and Nocebo effects: shared mechanisms. Nat Rev Neurol. 2022;18(10):624\u201335. https:\/\/doi.org\/10.1038\/s41582-022-00711-z.","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"12182_CR49","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.revmed.2018.04.002","volume":"39","author":"E Forestier","year":"2018","unstructured":"Forestier E, Gonnet F, Revil-Signorat A, Zipper AC. [Pathway to diagnosis and real-life experience of patients believing they are affected by chronic Lyme disease]. Rev Med Interne. 2018;39(12):912\u20137. https:\/\/doi.org\/10.1016\/j.revmed.2018.04.002.","journal-title":"Rev Med Interne"},{"issue":"1","key":"12182_CR50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12875-022-01736-5","volume":"23","author":"ME Baarsma","year":"2022","unstructured":"Baarsma ME, Claassen SA, van der Horst HE, Hovius JW, Sanders JM. Knowing the entire story - a focus group study on patient experiences with chronic Lyme-associated symptoms (chronic Lyme disease). BMC Prim Care. 2022;23(1):139. https:\/\/doi.org\/10.1186\/s12875-022-01736-5.","journal-title":"BMC Prim Care"},{"issue":"1","key":"12182_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/jamainternmed.2021.6454","volume":"182","author":"J Matta","year":"2022","unstructured":"Matta J, Wiernik E, Robineau O, Carrat F, Touvier M, Severi G, de Lamballerie X, Blanch\u00e9 H, Deleuze JF, Gouraud C, et al. Association of Self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med. 2022;182(1):19\u201325. https:\/\/doi.org\/10.1001\/jamainternmed.2021.6454.","journal-title":"JAMA Intern Med"},{"issue":"10444","key":"12182_CR52","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1016\/s0140-6736(24)00623-8","volume":"403","author":"B L\u00f6we","year":"2024","unstructured":"L\u00f6we B, Toussaint A, Rosmalen JGM, Huang WL, Burton C, Weigel A, Levenson JL, Henningsen P. Persistent physical symptoms: definition, genesis, and management. Lancet. 2024;403(10444):2649\u201362. https:\/\/doi.org\/10.1016\/s0140-6736(24)00623-8.","journal-title":"Lancet"},{"key":"12182_CR53","doi-asserted-by":"publisher","first-page":"101140","DOI":"10.1016\/j.lanepe.2024.101140","volume":"48","author":"A Toussaint","year":"2025","unstructured":"Toussaint A, Weigel A, L\u00f6we B. The overlooked burden of persistent physical symptoms: a call for action in European healthcare. Lancet Reg Health Eur. 2025;48:101140. https:\/\/doi.org\/10.1016\/j.lanepe.2024.101140.","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"12182_CR54","doi-asserted-by":"publisher","first-page":"e0247384","DOI":"10.1371\/journal.pone.0247384","volume":"16","author":"K Nilsson","year":"2021","unstructured":"Nilsson K, Skoog E, Jones V, Labb\u00e9 Sandelin L, Bj\u00f6rling C, Fridenstr\u00f6m E, Edvinsson M, M\u00e5rtensson A, Olsen B. A comprehensive clinical and laboratory evaluation of 224 patients with persistent symptoms attributed to presumed tick-bite exposure. PLoS ONE. 2021;16(3):e0247384. https:\/\/doi.org\/10.1371\/journal.pone.0247384.","journal-title":"PLoS ONE"},{"issue":"3","key":"12182_CR55","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/cid\/cit735","volume":"58","author":"K Strle","year":"2014","unstructured":"Strle K, Stupica D, Drouin EE, Steere AC, Strle F. Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema Migrans. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2014;58(3):372\u201380. https:\/\/doi.org\/10.1093\/cid\/cit735.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"3","key":"12182_CR56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/cdt3.74","volume":"9","author":"NA Bai","year":"2023","unstructured":"Bai NA, Richardson CS. Posttreatment Lyme disease syndrome and myalgic encephalomyelitis\/chronic fatigue syndrome: A systematic review and comparison of pathogenesis. Chronic Dis Transl Med. 2023;9(3):183\u201390. https:\/\/doi.org\/10.1002\/cdt3.74.","journal-title":"Chronic Dis Transl Med"},{"issue":"7","key":"12182_CR57","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/cid\/civ470","volume":"61","author":"DM Patrick","year":"2015","unstructured":"Patrick DM, Miller RR, Gardy JL, Parker SM, Morshed MG, Steiner TS, Singer J, Shojania K, Tang P. Lyme disease diagnosed by alternative methods: A phenotype similar to that of chronic fatigue syndrome. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2015;61(7):1084\u201391. https:\/\/doi.org\/10.1093\/cid\/civ470.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"9768","key":"12182_CR58","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/s0140-6736(11)60096-2","volume":"377","author":"PD White","year":"2011","unstructured":"White PD, Goldsmith KA, Johnson AL, Potts L, Walwyn R, DeCesare JC, Baber HL, Burgess M, Clark LV, Cox DL, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet. 2011;377(9768):823\u201336. https:\/\/doi.org\/10.1016\/s0140-6736(11)60096-2.","journal-title":"Lancet"},{"key":"12182_CR59","doi-asserted-by":"publisher","first-page":"e081318","DOI":"10.1136\/bmj-2024-081318","volume":"387","author":"D Zeraatkar","year":"2024","unstructured":"Zeraatkar D, Ling M, Kirsh S, Jassal T, Shahab M, Movahed H, Talukdar JR, Walch A, Chakraborty S, Turner T, et al. Interventions for the management of long Covid (post-covid condition): living systematic review. BMJ. 2024;387:e081318. https:\/\/doi.org\/10.1136\/bmj-2024-081318.","journal-title":"BMJ"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12182-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12182-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12182-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T09:13:38Z","timestamp":1764234818000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-12182-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12182"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12182-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Regional Committee on Medical and Health Research Ethics, South-East Norway (reference number 2018\/759). Informed consent was obtained from all participants, who were informed that they could withdraw their consent at any time. The study was carried out in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1663"}}